ArticleCommunications medicine2026
Global, regional, and national burden of injury associated internal hemorrhage in the abdomen and pelvis from 1990-2021.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInjury associated internal hemorrhage in the abdomen and pelvis (IAIHAP) is a major cause of preventable deaths, particularly in conflict zones. However, its global burden remains inadequately investigated. This study aimed to assess the burden of IAIHAP from 1990 to 2021.
methodUsing data from Global Burden of Disease Study 2021, this study analyzed IAIHAP burden across 204 countries and territories. Incidence, prevalence, and Years Lived with Disability (YLDs) were estimated. Temporal trends were analyzed using join-point regression. Burden estimates were stratified by sex, age, region, and socio-demographic index (SDI).
resultsDespite a significant decline in global age-standardized-incidence-rate (ASIR) from 186.44 to 135.40 per 100,000 population between 1990 and 2021 [Average Annual Percent Change (AAPC): -1.74], IAIHAP remains a substantial health challenge in 2021 with 10.59 million incident cases and 0.69 million YLDs. The decline is more pronounced in males (AAPC: -2.58) compared to females (AAPC: -0.92). High-middle SDI regions demonstrate the largest decline (AAPC: -2.35), while low SDI regions show modest decreases (AAPC: -0.72) with greater fluctuation. Conflict-affected countries, predominantly in low SDI regions, experience significant increases, with Afghanistan showing the highest rise (AAPC: 8.31).
conclusionsWhile global IAIHAP burden has declined over the past three decades, significant disparities persist across regions and development levels. The burden remains particularly high in conflict-affected and low-resource settings, highlighting the need for targeted interventions and improved emergency care infrastructure in vulnerable regions. CLINICAL TRIAL NUMBER: Not applicable.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.